Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
»
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Ageing Population
Robotics
Cybersecurity
Financial Data
Gold and Silver
Strategic Metals
The Cannabis Industry
The Golden Age of Video Games
US Basketball
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Ageing Population
Robotics
Cybersecurity
Financial Data
Gold and Silver
Strategic Metals
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Swiss Exchange
>
Novartis AG
NOVN
CH0012005267
NOVARTIS AG
(NOVN)
Add to my list
Report
Delayed Swiss Exchange -
02/26 11:31:25 am
78.19
CHF
-1.08%
02/26
Novartis Signs Development, Distribution Deal With BeiGene For Tislelizumab
MT
02/26
NOVARTIS
: to Co-Develop Cancer Drug With China's BeiGene
DJ
02/26
NOVARTIS
: strengthens Oncology pipeline with successful closing of tislelizumab in-licensing
PU
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about NOVARTIS AG
02/26
Novartis Signs Development, Distribution Deal With BeiGene For Tislelizumab
MT
02/26
NOVARTIS
: to Co-Develop Cancer Drug With China's BeiGene
DJ
02/26
NOVARTIS
: strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26
NOVARTIS
: Gets EU Nod for Label Update of Cosentyx in Psoriatic Arthritis
MT
02/26
NOVARTIS
: Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26
NOVARTIS
: Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/22
Novartis, Swiss Re, Others Back Switzerland's 2050 Net Zero Climate Goal
MT
02/19
NOVARTIS
: Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
02/18
NOVARTIS AG
: UBS reiterates its Buy rating
MD
02/18
NOVARTIS
: and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
02/18
NOVARTIS AG
: Deutsche Bank reiterates its Buy rating
MD
02/17
NOVARTIS
: Teams Up With Bill & Melinda Gates Foundation to Develop In Vivo Gene..
MT
02/17
NOVARTIS
: data show multiple sclerosis patients and nurses prefer Kesimpta Sens..
AQ
02/17
NOVARTIS
: Entresto granted expanded indication in chronic heart failure by FDA
AQ
02/17
NOVARTIS
: and Bill & Melinda Gates Foundation collaborate on therapy for sickle..
RE
More most relevant news
All news about NOVARTIS AG
02/26
Novartis Signs Development, Distribution Deal With BeiGene For Tislelizumab
MT
02/26
NOVARTIS
: to Co-Develop Cancer Drug With China's BeiGene
DJ
02/26
NOVARTIS
: strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26
NOVARTIS
: Gets EU Nod for Label Update of Cosentyx in Psoriatic Arthritis
MT
02/26
NOVARTIS
: Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26
NOVARTIS
: Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/25
WANTED
: more manufacturing space for vaccine push
RE
02/25
PRESS RELEASE
: Celonic AG : Celonic to Boost its Cell & Gene Therapy Production..
DJ
02/25
WANTED
: More high-tech manufacturing space for a global vaccine push
RE
02/23
Health Care Ticks Down As Investors Await Vaccine Updates -- Health Care Roun..
DJ
More news
News in other languages on NOVARTIS AG
11:23a
Presseschau vom Wochenende 09 (27./28. Februar)
02/26
Aktien Schweiz Schluss
: Inflationssorgen und Gewinnmitnahmen belasten SMI
02/26
Bourse Zurich
: les indices terminent dans le rouge, entrainés par Wall Street
02/26
Aktien Schweiz gehen mit deutlichen Abschlägen ins Wochenende
02/26
WOCHENVORSCHAU
: Termine bis 12. März 2021
02/26
NOVARTIS
: finalisation de l'accord avec BeiGene
02/26
NOVARTIS
: will Krebsmedikament gemeinsam mit Chinas Beigene entwickeln
02/26
Novartis finalise l'acquisition d'une licence en oncologie auprès de Beigene
02/26
Novartis schliesst Einlizenzierung von Tislelizumab ab
02/26
Aktien Schweiz
: Erholung auf Vortagesschluss dank Schwergewichten
More news
Analyst Recommendations on NOVARTIS AG
02/18
NOVARTIS AG
: UBS reiterates its Buy rating
MD
02/18
NOVARTIS AG
: Deutsche Bank reiterates its Buy rating
MD
02/16
NOVARTIS AG
: Receives a Buy rating from Deutsche Bank
MD
02/10
NOVARTIS AG
: Deutsche Bank reiterates its Buy rating
MD
02/09
NOVARTIS AG
: Deutsche Bank maintains a Buy rating
MD
More recommendations
Press releases
02/26
NOVARTIS
: strengthens Oncology pipeline with successful closing of tislelizumab..
PU
02/26
NOVARTIS
: Federal Court Holds Section 8.2 Of The PMNOC Regulations Does Not Imp..
AQ
02/26
NOVARTIS
: Cosentyx® gains EU label update for first-of-its-kind MAXIMISE data i..
PU
02/19
NOVARTIS
: Gates Foundation to fund Novartis' development of a sickle cell disea..
AQ
02/18
NOVARTIS
: and the Bill and Melinda Gates Foundation collaborate to discover and..
AQ
More press releases
Powered by Scoopnest.com
Analysis
Wanted: More high-tech manufacturing space for a global vaccine push
More Must read
Stock Pick
NOVARTIS AG
Back to basics
More Recommendations
Official Publications
01/26
Press Release
01/26
Annual results
01/26
Annual results
01/26
Annual results
2020
Financial report
2020
Press Release
More Official Publications
Upcoming event on NOVARTIS AG
03/01/21
Cowen & Co. Health Care Conference
Company calendar
Upcoming sector events
03/01/21
PERRIGO COMPANY PLC
: FY 2020 Earnings Release
03/01/21
ZAI LAB LIMITED
: FY 2020 Earnings Release
03/03/21
VIATRIS INC.
: FY 2020 Earnings Release (Projected)
03/03/21
VIFOR PHARMA AG
: FY 2020 Earnings Release
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals
Slave